Bartlett & CO. Wealth Management LLC Sells 25 Shares of Chemed Corporation $CHE

Bartlett & CO. Wealth Management LLC lowered its position in shares of Chemed Corporation (NYSE:CHE) by 10.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 225 shares of the company’s stock after selling 25 shares during the quarter. Bartlett & CO. Wealth Management LLC’s holdings in Chemed were worth $110,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Fuller & Thaler Asset Management Inc. raised its position in shares of Chemed by 249.3% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 130,037 shares of the company’s stock valued at $80,015,000 after purchasing an additional 92,813 shares during the period. Woodline Partners LP lifted its position in shares of Chemed by 2,681.0% in the first quarter. Woodline Partners LP now owns 58,178 shares of the company’s stock valued at $35,798,000 after acquiring an additional 56,086 shares in the last quarter. Nuveen LLC bought a new position in shares of Chemed in the first quarter worth about $30,527,000. Jacobs Levy Equity Management Inc. bought a new position in shares of Chemed in the first quarter worth about $26,059,000. Finally, Candriam S.C.A. grew its position in shares of Chemed by 207.7% during the first quarter. Candriam S.C.A. now owns 45,178 shares of the company’s stock worth $27,799,000 after purchasing an additional 30,495 shares in the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the company. Oppenheimer lowered their price target on Chemed from $650.00 to $580.00 and set an “outperform” rating on the stock in a report on Thursday, July 31st. Wall Street Zen cut shares of Chemed from a “buy” rating to a “hold” rating in a research report on Saturday, July 5th. Bank of America dropped their target price on shares of Chemed from $610.00 to $595.00 and set a “buy” rating for the company in a research report on Wednesday, September 10th. Jefferies Financial Group raised shares of Chemed from a “hold” rating to a “buy” rating and raised their target price for the company from $490.00 to $550.00 in a research note on Tuesday, September 2nd. Finally, Royal Bank Of Canada reduced their price target on shares of Chemed from $640.00 to $589.00 and set an “outperform” rating on the stock in a report on Thursday, July 31st. Four investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $578.50.

Chemed Stock Performance

CHE stock opened at $441.44 on Friday. The firm has a fifty day moving average price of $449.24 and a 200 day moving average price of $517.53. Chemed Corporation has a fifty-two week low of $408.42 and a fifty-two week high of $623.60. The firm has a market cap of $6.43 billion, a PE ratio of 22.70, a price-to-earnings-growth ratio of 2.56 and a beta of 0.43.

Chemed (NYSE:CHE) last released its quarterly earnings data on Tuesday, July 29th. The company reported $4.27 EPS for the quarter, missing the consensus estimate of $6.02 by ($1.75). Chemed had a net margin of 11.56% and a return on equity of 25.83%. The business had revenue of $618.80 million for the quarter, compared to the consensus estimate of $650.60 million. During the same quarter last year, the business earned $5.47 EPS. Chemed’s revenue for the quarter was up 3.8% compared to the same quarter last year. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. On average, equities analysts predict that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Monday, August 11th were paid a dividend of $0.60 per share. The ex-dividend date of this dividend was Monday, August 11th. This is an increase from Chemed’s previous quarterly dividend of $0.50. This represents a $2.40 annualized dividend and a yield of 0.5%. Chemed’s payout ratio is presently 12.34%.

Insider Buying and Selling

In related news, Director George J. Walsh III purchased 200 shares of the firm’s stock in a transaction that occurred on Monday, August 4th. The shares were bought at an average price of $417.10 per share, for a total transaction of $83,420.00. Following the acquisition, the director owned 3,523 shares of the company’s stock, valued at approximately $1,469,443.30. This represents a 6.02% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Nicholas Michael Westfall sold 10,012 shares of the firm’s stock in a transaction on Monday, August 4th. The stock was sold at an average price of $421.91, for a total value of $4,224,162.92. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 13,162 shares of company stock valued at $5,677,511. Insiders own 3.29% of the company’s stock.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.